Mrs. Annette Rose Collins is a pharmacist who is specialized in Pharmacotherapy in Brecksville, Ohio. Patients can reach her at 10000 Brecksville Rd # 119b, Brecksville or contact her on 440-526-3030. Active license number of Mrs. Annette Rose Collins is 03-3-25711 for Pharmacotherapy in Ohio. Mrs. Annette Rose Collins is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Mrs. Annette Rose Collins speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mrs. Annette Rose Collins are as mentioned below.
NPI Number:
1033205307
NPI Enumeration Date:
05 Oct, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mrs. Annette Rose Collins are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
03-3-25711
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
10000 Brecksville Rd # 119b, Brecksville, Ohio
Zip:
44141-3204
Phone Number:
440-526-3030
Fax Number:
440-717-2844
Patients can reach Mrs. Annette Rose Collins at 10000 Brecksville Rd # 119b, Brecksville, Ohio or can call on phone at 440-526-3030.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.